Huntingtin takes a trip: harmful proteins pass between brain cells

Huntingtin takes a trip: harmful proteins pass between brain cells

Harmful misfolded huntingtin can travel between brain cells via messenger particles called exosomes

Leora FoxJune 06, 2016

Important drug targets yielded by new genetic study of HD

Important drug targets yielded by new genetic study of HD

A genetic study confirms that minute differences in DNA repair genes can influence the age of HD symptom onset.

Leora FoxMay 02, 2016

Thinking clearly about the earliest symptoms of HD and which brain regions control them

Thinking clearly about the earliest symptoms of HD and which brain regions control them

HD reaches more brain structures than we thought: new research broadens our understanding of the earliest signs of HD

Dr Tamara MaiuriApril 18, 2016

How NOT to write a news article about a clinical trial

How NOT to write a news article about a clinical trial

A confusing story about a huntingtin lowering trial is published in the Telegraph, but cool new stuff is happening!

Dr Jeff CarrollMarch 11, 2016

Huntington's Disease Therapeutics Conference 2016 - day 3

Huntington's Disease Therapeutics Conference 2016 - day 3

Stem cells and modeling Huntington's disease in our final Therapeutics Conference report

Dr Jeff CarrollFebruary 28, 2016

Huntington's Disease Therapeutics Conference 2016 - day 2

Huntington's Disease Therapeutics Conference 2016 - day 2

Strategies for getting rid of mutant huntingtin & clinical trial updates: day 2 of the HD therapeutics conference

Dr Jeff CarrollFebruary 28, 2016

Could a new "jaw-dropping" breakthrough help treat Huntington's Disease?

Could a new "jaw-dropping" breakthrough help treat Huntington's Disease?

The news has recently been full of stories about CRISPR, a new "jaw-dropping" DNA-editing technology. Hype or hope?

Dr Jeff CarrollFebruary 25, 2016

Huntington's Disease Therapeutics Conference 2016 - day 1

Huntington's Disease Therapeutics Conference 2016 - day 1

Proteins and DNA - Jeff and Ed report from day 1 of the 2016 #huntingtonsdisease therapeutics conference

Dr Ed WildFebruary 25, 2016

Harnessing the power of viruses to treat Huntington's disease

Harnessing the power of viruses to treat Huntington's disease

Researchers design a virus to more effectively deliver gene-silencing drugs throughout the brain.

Leora FoxFebruary 03, 2016

Through a Broader Lens: Looking at Non-Motor Symptoms in HD

Through a Broader Lens: Looking at Non-Motor Symptoms in HD

Sleep deficits precede motor problems in HD

Melissa ChristiansonJanuary 25, 2016

Looking Past the Spin: Results from a Clinical Trial of Cysteamine

Looking Past the Spin: Results from a Clinical Trial of Cysteamine

Phase 2/3 clinical trial results prove inconclusive for Huntington's drug cysteamine.

Melissa ChristiansonDecember 18, 2015